Astellas sells U.S. manufacturing subsidiary to Avara
Client(s) Astellas Pharma Inc.
Jones Day advised Astellas Pharma Inc. in the transfer of its wholly owned manufacturing subsidiary Astellas Pharma Technologies, Inc. to Avara Norman Pharmaceutical Services, Inc. Astellas Pharma Technologies, Inc. will be renamed Avara Pharmaceutical Technologies, Inc.